Aurora Cannabis Inc. (ACB) Financials
ACB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 616.1 million | 195.3 million |
| 2023-09-30 | 602.2 million | 198.2 million |
| 2023-06-30 | 819.1 million | 318.8 million |
| 2023-03-31 | 684.7 million | 302.4 million |
ACB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -6.1 million | 2.1 million |
| 2023-09-30 | -25.8 million | 3.4 million |
| 2023-06-30 | -27.0 million | 2.6 million |
| 2023-03-31 | ? | ? |
ACB Net Income
No data available :(
ACB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 112.0 million | - | 36.5 million |
| 2023-09-30 | 94.9 million | - | 37.2 million |
| 2023-06-30 | 331.7 million | - | 35.3 million |
| 2023-03-31 | 173.7 million | - | 36.4 million |
ACB Shares Outstanding
ACB Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.1 million | 589587 | 18.9 million | 9.1 million |
| 2023-09-30 | 3.1 million | 696074 | 20.1 million | 9.3 million |
| 2023-06-30 | 6.8 million | 1.9 million | 25.7 million | 12.4 million |
| 2023-03-31 | 2.6 million | - | - | - |
ACB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 48.6 million | 33.6 million |
| 2023-09-30 | 46.7 million | 21.3 million |
| 2023-06-30 | 37.9 million | 34.6 million |
| 2023-03-31 | - | - |
ACB
Price: $6.42
52 week price:
Earnings Per Share: -57.84 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 13.9 million
Market Capitalization: 350.3 million